If Retraction Watch was actually a business, as opposed — for the moment, anyway — to a labor of love for two guys with day jobs, 2011 would have been a very good year for business. It was a year that will probably see close to 400 retractions, including a number of high-profile ones, once … Continue reading The Year of the Retraction: A look back at 2011
Last week, we reported that a group of Harvard researchers had retracted a paper in Blood for “multiple instances of duplicate (redundant) publication of data, text, and images that are nonessential to the paper.” The retraction notice referred to a paper in the Journal of Biological Chemistry (JBC): The redundancies are between the above-cited Blood … Continue reading Second retraction by Harvard group studying cannabinoids, this one in JBC
The journal Blood has retracted a paper from a group of prestigious Harvard researchers after the article, which appeared in January 2011, was found to have multiple instances of material — text, data and other elements — that had appeared in a previous publication from several of the authors. The article was titled “Cannabinoid receptor … Continue reading “Nonessential” duplication leads to retraction of Blood cannabinoid paper